British Journal of Ophthalmology · 2009 · 18 citations · 12 references
Public HealthChild HealthInfectious Disease ControlDisease PreventionEpidemiologyPediatric EpidemiologyChild Health EpidemiologyDisease ControlInfection SurveillanceInfectious Disease PreventionPediatric Antibiotic TherapyPublic Health ResponseChildhood Infection PreventionChildhood Infectious Disease PreventionEnvironmental ImprovementMultilevel Ordinal ModelsOrdinal Regression ModelsOrdinal Severity ClassificationTrachoma EpidemiologyTrachoma Surveillance
AIMS: The WHO recommends the SAFE (surgery, antibiotics, facial cleanliness and environmental improvement) strategy for trachoma control. We aimed to investigate the association between active trachoma and community intervention with antibiotics, facial cleanliness, environmental improvement (A,F,E) components of SAFE in five trachoma hyperendemic districts of Amhara region, Ethiopia. METHODS: Cluster random surveys were undertaken to evaluate SAFE following 3 years of interventions. Children aged 1-9 years were examined for trachoma signs using the WHO simplified grading system and structured questionnaires used to assess uptake of A, F and E. Active trachoma signs (trachomatous inflammation-follicular (TF) and trachomatous inflammation-intense (TI)) were used to derive an ordinal severity score where TI was considered more severe than TF. Associations between active trachoma and potential factors were investigated using ordinal logistic multilevel regression models. RESULTS: A total of 1813 children aged 1-9 years were included in the analysis. Factors independently associated with reduced odds of active trachoma signs were: number of times treated with azithromycin (p-trend=0.026); months since last mass azithromycin distribution (p-trend<0.001); clean face (OR=0.6; 95% CI 0.5 to 0.8); and household pit latrine (OR=0.8; 95% CI 0.7 to 0.9). CONCLUSION: These findings are important, since they make the case for continued implementing the A,F,E interventions simultaneously, and suggest appropriate timing of SAFE evaluations within 6-12 months after the last mass azithromycin distribution.
12
A simple system for the assessment of trachoma and its complications.
B Thylefors, C. R. Dawson, B R Jones et al. · PubMed · 1987 · 789 citations
Azithromycin in control of trachoma
Julius Schachter, Shila K West, David Mabey et al. · The Lancet · 1999 · 299 citations · Full text
Impact of face-washing on trachoma in Kongwa, Tanzania
Sheila K. West, Beatriz Muñoz, Megan Lynch et al. · The Lancet · 1995 · 232 citations
Effect of fly control on trachoma and diar rhoea
Paul M. Emerson, Steve W. Lindsay, Gijs Walraven et al. · The Lancet · 1999 · 212 citations
Life Sciences, Infectious Disease Control, Infectious Diseases +4